Live Breaking News & Updates on Centre Clinical Trial To Evaluate The Safety

Stay updated with breaking news from Centre clinical trial to evaluate the safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics to take part in upcoming scientific and industry conferences in early 2022

DGAP-News: Atriva Therapeutics GmbH / Key word(s): Conference Atriva Therapeutics to take part in upcoming scientific and industry conferences in early 2022 20.12.2021 / 10:00 The ....

New York , United States , United Kingdom , City Of , Eva Bauer Raimund Gabriel , Stephan Stenglein , Kostenloser Wertpapierhandel , Marriott Marquis , Rainer Lichtenberger , Mc Services , Vp Business Development , Centre Clinical Trial To Evaluate The Safety , Distribution Services , Atriva Therapeutics Gmbh , Therapeutics Gmbh , Chief Medical Officer , New York Marriott Marquis , Digital Partnering , Investor Relations , Multi Centre Clinical Trial , Adult Hospitalized Patients , Corporate News , Regulatory Announcements ,

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics: Participation in upcoming scientific and industry conferences

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics: Participation in upcoming scientific and industry conferences
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , City Of , Deutsche Biotechnologietage , Eva Bauer Raimund Gabriel , Kostenloser Wertpapierhandel , Internationales Congresscenter , Rainer Lichtenberger , Hilton Waldorf , Business Development At Atriva Therapeutics , Mc Services , Congress Center Basel , Centre Clinical Trial To Evaluate The Safety , Distribution Services , Atriva Therapeutics Gmbh , Therapeutics Gmbh , Atriva Therapeutics , Investor Relations , Multi Centre Clinical Trial , Adult Hospitalized Patients , Corporate News , Regulatory Announcements ,

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding
Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding
21.04.2021 / 16:03
Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding
German Federal Ministry of Education and Research (BMBF) awards Atriva up to €11.4 million for the clinical development of a drug to treat COVID-19
Product candidate ATR-002 could help hospital patients with COVID-19 avoid ventilation and intensive care treatment
Targeting RNA viruses and acting in the host cell, drug candidate can retain full activity even with SARS-CoV-2 variants
Therapeutic aims to inhibit replication of virus and to prevent overshooting immune response ....

Nordrhein Westfalen , Eva Bauer Raimund Gabriel , Kostenloser Wertpapierhandel , Rainer Lichtenberger , Mc Services , German Federal Ministry Of Education , Centre Clinical Trial To Evaluate The Safety , Distribution Services , Atriva Therapeutics Gmbh , Federal Funding , Federal Ministry , Therapeutics Gmbh , German Federal Ministry , Investor Relations , Multi Centre Clinical Trial , Adult Hospitalized Patients , Cell Biol , Planzo Antiviral Res , Corporate News , Regulatory Announcements , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , ஈவா பாயர் ரேமூஂட் கேப்ரியல் , ம்ஸீ சேவைகள் , ஜெர்மன் கூட்டாட்சியின் அமைச்சகம் ஆஃப் கல்வி , விநியோகம் சேவைகள் , கூட்டாட்சியின் நிதி ,

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics Announces Changes to Management

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics Announces Changes to Management
Atriva Therapeutics Announces Changes to Management
13.04.2021 / 09:30
Atriva Therapeutics Announces Changes to Management
- Olaf Althaus appointed Chief Financial Officer
- Stephan Stenglein, M.D., recently joined as Chief Medical Officer
- Proven track record and 20+ years of experience in their respective fields of expertise
Tübingen (Germany), April 13, 2021 - Atriva Therapeutics GmbH, a biopharmaceutical company that is pioneering the development of host-targeting antiviral therapies, today announced two changes to its management team. Olaf Althaus was appointed Chief Financial Officer, effective May 2020, while Stephan Stenglein, M.D., was named Chief Medical Officer, effective February 2021. ....

Frankfurt Am Main , Nordrhein Westfalen , City Of , United Kingdom , Eva Bauer Raimund Gabriel , Olaf Althaus , Stephan Stenglein , Kostenloser Wertpapierhandel , Gernot Rohde , Aeterna Zentaris Gmb , Rainer Lichtenberger , Mc Services , Global Program , Global Program Clinical Head , Centre Clinical Trial To Evaluate The Safety , Distribution Services , Stage Development Respiratory At Astrazeneca , Shire Plc , Goethe University Hospital , Karlsruhe University Diplom Wirtschaftsingenieurwesen , Vp Clinical Sciences At Glenmark Pharmaceuticals , Atriva Therapeutics Gmbh , Therapeutics Announces Changes , Chief Financial , Chief Medical , Therapeutics Gmbh ,